CHROMADEX, INC. - DARTMOUTH RESTATED AND AMENDED EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 12th, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products • New York
TRUSTEES OF DARTMOUTH COLLEGE, a non-profit educational and research institution existing under the laws of the State of New Hampshire, and being located at Hanover, New Hampshire 03755, hereinafter called Dartmouth,
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.Side Letter Agreement • May 12th, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. JOINT OWNERSHIP MANAGEMENT AGREEMENTJoint Ownership Management Agreement • May 12th, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SECOND AMENDMENT TO THE CHROMADEX, INC. -...Exclusive License Agreement • May 12th, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products
This Amendment (this “Amendment”), effective as of this 1st day of January, 2022 (the “Effective Date”), to the ChromaDex, Inc. - Dartmouth Restated and Amended Exclusive License Agreement, dated September 2019, as amended on December 29, 2020 (“License Agreement”), is made by and between:
AMENDMENT TO THE CHROMADEX, INC. - DARTMOUTH RESTATED AND AMENDED EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 12th, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products
This Amendment (this “Amendment”), dated as of this 29th day of December, 2020 with effect from and after March 13, 2017 (the “Amendment Effective Date”), to the ChromaDex, Inc. - Dartmouth Restated and Amended Exclusive License Agreement, dated September 2019 (“License Agreement”), is made by and between:
ChromaDex CorporationTransition and Separation Agreement • May 12th, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
This letter sets forth the substance of the transition and separation agreement (the “Agreement”) that ChromaDex Corporation (the “Company”) is offering to you to aid in your employment transition.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDMENT TO / JOINT OWNERSHIP MANAGEMENT...Joint Ownership Management Agreement • May 12th, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products
THIS AMENDMENT is entered into this 10th day of March 2022 (the “Effective Date of the Amendment”), by and between ChromaDex, Inc. (hereinafter referred to as “CHROMADEX”) and The Queen’s University of Belfast (hereinafter referred to as the “COMPANY”).
